Bilaketaren emaitzak - Keith L. Ligon

Findu emaitzak
  1. 1
    Molecular pathologic diagnosis of epidermal growth factor receptor

    Molecular pathologic diagnosis of epidermal growth factor receptor nork Cécile L. Maire, Keith L. Ligon

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Glioblastoma targeted therapy: updated approaches from recent biological insights

    Glioblastoma targeted therapy: updated approaches from recent biological insights nork Mehdi Touat, Ahmed Idbaïh, Marc Sanson, Keith L. Ligon

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Paraxis: A Basic Helix-Loop-Helix Protein Expressed in Paraxial Mesoderm and Developing Somites

    Paraxis: A Basic Helix-Loop-Helix Protein Expressed in Paraxial Mesoderm and Developing Somites nork Rob Burgess, Peter Cserjesi, Keith L. Ligon, Eric N. Olson

    Argitaratua 1995
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Neoplastic cells are a rare component in human glioblastoma microvasculature

    Neoplastic cells are a rare component in human glioblastoma microvasculature nork Fausto J. Rodríguez, Brent A. Orr, Keith L. Ligon, Charles G. Eberhart

    Argitaratua 2012
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis.

    Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. nork Joseph M. Miano, Peter Cserjesi, Keith L. Ligon, Muthu Periasamy, Eric N. Olson

    Argitaratua 1994
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence

    Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence nork Akitake Mukasa, Jill Wykosky, Keith L. Ligon, Lynda Chin, Webster K. Cavenee, Frank B. Furnari

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Current clinical development of PI3K pathway inhibitors in glioblastoma

    Current clinical development of PI3K pathway inhibitors in glioblastoma nork Patrick Y. Wen, E. Q. Lee, David A. Reardon, Keith L. Ligon, W.K. Alfred Yung

    Argitaratua 2012
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43

    Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43 nork Jessian L. Munoz, Vivian Rodriguez‐Cruz, Steven J. Greco, Shakti Ramkissoon, Keith L. Ligon, Pranela Rameshwar

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity

    Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity nork Jessian L. Munoz, Sarah A. Bliss, Steven J. Greco, Shakti Ramkissoon, Keith L. Ligon, Pranela Rameshwar

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology

    The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology nork Daniel Cagney, Joohee Sul, Raymond Y. Huang, Keith L. Ligon, Patrick Y. Wen, Brian M. Alexander

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Intracranial myxoid mesenchymal tumors with <i>EWSR1</i>–<i>CREB</i> family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity?

    Intracranial myxoid mesenchymal tumors with <i>EWSR1</i>–<i>CREB</i> family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? nork Tejus Bale, Angélica Oviedo, Harry P. Kozakewich, Caterina Giannini, Phani K. Davineni, Keith L. Ligon, Sanda Alexandrescu

    Argitaratua 2017
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas

    Prominin-1 (CD133) Defines Both Stem and Non-Stem Cell Populations in CNS Development and Gliomas nork Karl Holmberg Olausson, Cécile L. Maire, Sam Haidar, Jason Ling, Emily R. Learner, Monica Nistér, Keith L. Ligon

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    A Novel Somatic Mouse Model to Survey Tumorigenic Potential Applied to the Hedgehog Pathway

    A Novel Somatic Mouse Model to Survey Tumorigenic Potential Applied to the Hedgehog Pathway nork Junhao Mao, Keith L. Ligon, Elena Y. Rakhlin, Sarah P. Thayer, Roderick T. Bronson, David H. Rowitch, Andrew P. McMahon

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas

    Expression of Oligodendroglial and Astrocytic Lineage Markers in Diffuse Gliomas nork Audrey Rousseau, Catherine L. Nutt, Rebecca A. Betensky, A. John Iafrate, Moonjoo Han, Keith L. Ligon, David H. Rowitch, David N. Louis

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma

    Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma nork Shumin Dong, Catherine L. Nutt, Rebecca A. Betensky, Anat Stemmer‐Rachamimov, Nicholas Denko, Keith L. Ligon, David H. Rowitch, David N. Louis

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Glioproliferative Lesion of the Spinal Cord as a Complication of “Stem-Cell Tourism”

    Glioproliferative Lesion of the Spinal Cord as a Complication of “Stem-Cell Tourism” nork Aaron L. Berkowitz, Michael B. Miller, Saad Mir, Daniel Cagney, Vamsidhar Chavakula, Indira Guleria, Ayal A. Aizer, Keith L. Ligon, H. John

    Argitaratua 2016
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Expression of p16Ink4a Compensates for <i>p18Ink4c</i> Loss in Cyclin-Dependent Kinase 4/6–Dependent Tumors and Tissues

    Expression of p16Ink4a Compensates for <i>p18Ink4c</i> Loss in Cyclin-Dependent Kinase 4/6–Dependent Tumors and Tissues nork Matthew R. Ramsey, Janakiraman Krishnamurthy, Xin‐Hai Pei, Chad Torrice, Weili Lin, Daniel R. Carrasco, Keith L. Ligon, Yue Xiong, Norman E. Sharpless

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort

    Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort nork J. Bryan Iorgulescu, Maya Harary, Cheryl K. Zogg, Keith L. Ligon, David A. Reardon, F. Stephen Hodi, Ayal A. Aizer, Timothy R. Smith

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Machine learning for cryosection pathology predicts the 2021 WHO classification of glioma

    Machine learning for cryosection pathology predicts the 2021 WHO classification of glioma nork MacLean P. Nasrallah, Junhan Zhao, Cheng Che Tsai, David M. Meredith, Eliana Marostica, Keith L. Ligon, Jeffrey A. Golden, Kun‐Hsing Yu

    Argitaratua 2023
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    RESEARCH ARTICLE: Myelin Abnormalities without Oligodendrocyte Loss in Periventricular Leukomalacia

    RESEARCH ARTICLE: Myelin Abnormalities without Oligodendrocyte Loss in Periventricular Leukomalacia nork Saraid S. Billiards, Robin L. Haynes, Rebecca D. Folkerth, Natalia S. Borenstein, Felicia Trachtenberg, David H. Rowitch, Keith L. Ligon, Joseph J. Volpe, Hannah C. Kinney

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: